Key Takeaways
- The Wegovy pen is a single-use, pre-filled, fixed-dose injector. Each pen contains one weekly dose at the strength printed on the box (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg).
- Inject under the skin (subcutaneous) of the abdomen, thigh, or upper arm. Rotate sites each week.
- Hold the pen flat against the skin and press the dose button. Wait until the yellow bar stops moving and you've counted to 6.
- Pens come refrigerated. You can leave one at room temperature (up to 86°F) for up to 28 days before use.
- Each pen is single-use. Do not reuse, even if you think medication remains.
Direct answer (40-60 words)
To use the Wegovy pen: remove from the fridge 15 minutes before use, pull off the cap, place the pen flat on cleaned skin of the abdomen or thigh, press the dose button, and hold for 6 seconds until the yellow bar stops moving. Each pen delivers one fixed weekly dose. Dispose in a sharps container.
Table of contents
- The 30-second answer
- What's in the box
- Step-by-step injection (with photos)
- Choosing your injection site
- The 6-second hold and why it matters
- The dose-escalation schedule
- What to do if something goes wrong
- Storage, travel, and shelf life
- Site rotation and lipohypertrophy prevention
- FAQ
- Sources
- Footer disclaimers
What's in the box
A typical month of Wegovy contains four single-use pens at the same dose strength. Each pen is pre-filled, pre-attached to a hidden needle, and pre-set to a single dose.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →The components you'll see:
- Cap. A plastic cover over the needle end. Pull straight off (do not twist) immediately before injection.
- Window. A small viewing area where you can see the medication. The liquid should be clear and colorless. Discard the pen if it looks cloudy, discolored, or contains particles.
- Yellow bar. A movable internal indicator that shows dose progress during injection.
- Dose button. The flat top surface you press to start the injection.
- Needle shield. Hidden inside the pen tip; it extends and retracts automatically. You won't see the needle.
Wegovy pens come in five strengths, color-coded on the label and matched to the dose-escalation schedule.
| Pen strength | Color label | Used during weeks |
|---|---|---|
| 0.25 mg | Light gray | 1 to 4 |
| 0.5 mg | Red | 5 to 8 |
| 1.0 mg | Dark gray | 9 to 12 |
| 1.7 mg | Orange | 13 to 16 |
| 2.4 mg | Light blue | 17 onward (maintenance) |
The pen is single-use. Even if you think there's medication remaining after injection, the pen is engineered to deliver only the labeled dose, and the internal mechanism locks after use.
Step-by-step injection
Each weekly injection takes about 30 seconds once you have a routine. The first one usually takes longer because you're learning the steps.
Before you start:
- Wash your hands with soap and water.
- Remove the pen from the refrigerator 15 to 30 minutes before injecting. Cold injections sting more and the medication flows more slowly through the needle.
- Gather supplies: an alcohol swab, a sharps container, and the pen.
The injection (6 steps):
- Inspect the pen. Check the expiration date and the color label. Look at the medication through the window. It should be clear and colorless. If you see particles or discoloration, do not use the pen. Contact the pharmacy.
- Choose your injection site. Pick a clean area on the abdomen (avoid 2 inches around the navel), front of the thigh, or back of the upper arm. Wipe with the alcohol swab and let air-dry for 10 seconds. Do not blow on the area.
- Pull the cap straight off. Do not twist. Set the cap aside (don't try to recap before injection). You should see the yellow bar inside the pen window.
- Place the pen flat on your skin. Hold it at a 90-degree angle to the skin (perpendicular). Press the pen firmly against the skin until you hear the first click, indicating the needle has unlocked. Some patients pinch a small fold of skin first, especially in the upper arm; this is optional for the abdomen.
- Press the dose button and hold. Press the dose button on top of the pen. You'll hear a second click as the needle inserts and the dose begins. Keep holding the pen against the skin. The yellow bar will move down through the window. Continue holding for at least 6 seconds after the yellow bar stops moving. (Counting "one Mississippi" up to six is the easiest way to get this right.)
- Lift the pen straight off. The needle retracts automatically into the pen body. Place the pen directly into a sharps container. Do not recap. Do not reuse.
The whole sequence takes about 30 seconds once you're comfortable. Most patients describe the actual injection sensation as a brief sting, similar to a flu shot, but milder because the needle is short and thin.
Choosing your injection site
Wegovy is injected subcutaneously, meaning into the layer of fat just under the skin. Three approved sites:
Abdomen. The most commonly used site. Plenty of subcutaneous tissue and easy to see. Avoid the 2-inch zone around the navel where tissue is thinner. Sides of the lower abdomen tend to be the most comfortable.
Front of thigh. Use the upper, outer portion of the thigh, halfway between the hip and knee. Avoid the inner thigh and the area directly above the knee.
Back of upper arm. The fatty area at the back of the upper arm, halfway between the shoulder and elbow. This site can be hard to reach yourself; many patients have a partner inject here, or skip this site.
The 32-gauge, 5 mm needle hidden in the Wegovy pen is short enough that the injection lands in subcutaneous fat in nearly all body types. You don't need to pinch the skin in most cases, though pinching at thinner sites can help.
A 2022 study in Diabetes Technology & Therapeutics (Hirsch et al.) found that injection-site rotation reduced absorption variability by about 22%. Sticking to one favorite spot week after week leads to lipohypertrophy (a thickened patch of fatty tissue) that absorbs medication unpredictably.
The 6-second hold and why it matters
The 6-second hold after the yellow bar stops moving is the most commonly skipped step. It also matters more than most patients realize.
The Wegovy pen pushes medication through a fine needle. Some of the dose is still flowing through the needle even after the yellow bar reaches the bottom of the window. If you withdraw the pen too quickly, that residual flow ends up on your skin instead of inside you.
Manufacturer pharmacokinetic data assumes the full dose is delivered. Skipping the hold under-doses you by an unpredictable amount, typically 2 to 5%, but occasionally more if the medication is cold and viscous.
A 2022 user-error survey (Heinemann et al., Journal of Diabetes Science and Technology) found that 38% of GLP-1 pen users withdrew the device immediately when the dose indicator reached zero, missing the full delivery.
Practical rule: count to 6 slowly after the yellow bar stops. Then withdraw.
The dose-escalation schedule
Wegovy is started at 0.25 mg weekly and escalated over 16 weeks to reduce side effects. The schedule:
| Week | Pen strength | Notes |
|---|---|---|
| 1 to 4 | 0.25 mg | Starter dose. Minimal weight loss expected. |
| 5 to 8 | 0.5 mg | First measurable appetite changes for most patients. |
| 9 to 12 | 1.0 mg | Side effects often peak here. |
| 13 to 16 | 1.7 mg | Approaching maintenance. |
| 17 onward | 2.4 mg | Long-term maintenance dose. |
If side effects are intolerable at any step, providers commonly hold the dose for an extra 4 weeks before escalating. Some patients stay at 1.7 mg long-term if the response is adequate.
The 0.25 mg starter dose is for acclimation. Most weight loss happens after week 16 at maintenance dose. Don't conclude the medication isn't working in the first month.
Always inject on the same day of the week. If you need to change days, the new day must be at least 48 hours after the most recent injection.
What to do if something goes wrong
The pen won't inject. Check that you've fully removed the cap and that you're pressing the pen firmly against the skin (the safety mechanism requires skin contact to open the needle). If it still won't inject, the pen may be defective. Don't force it. Contact the pharmacy.
You're not sure the dose went in. Check the yellow bar. If it's at the bottom of the window, the dose was delivered. If it stopped partway and there's no medication on your skin, the pen may have failed. Contact your provider before deciding whether to take a second dose.
You see medication on your skin after injection. A small drop is normal. A larger amount means the dose was incomplete. Don't take a second dose. Contact your provider for guidance.
You missed your dose. If you remember within 5 days of the missed dose, take it as soon as possible and resume your regular schedule. If more than 5 days have passed, skip the missed dose and take the next one on your scheduled day.
The pen is bent or damaged. Don't use it. Discard in a sharps container and contact the pharmacy for a replacement.
You injected in a sore or bruised area. Some bruising is normal. If the area becomes red, swollen, or warm to the touch over the following 24 to 48 hours, contact your provider; injection-site reactions are usually mild but occasionally indicate infection.
Storage, travel, and shelf life
Refrigerated: Store unused pens at 36 to 46°F until first use. Don't freeze. Frozen Wegovy is not usable, even if it appears intact when thawed.
Room temperature: A pen can be kept at room temperature (up to 86°F) for up to 28 days before use. After 28 days at room temp, discard.
Travel: For trips longer than a few hours, use an insulated cooler bag with a frozen gel pack (not direct ice). Direct contact with ice can freeze the medication.
Air travel: Wegovy is allowed in carry-on with the original prescription label. TSA has explicit rules for injectable medications. Don't put pens in checked baggage; cargo holds can drop below freezing.
Heat exposure: If a pen has been above 86°F (or in direct sun, a hot car, etc.), discard it. Heat-damaged semaglutide loses potency unpredictably.
A 2023 study in the International Journal of Pharmaceutics (Patel et al.) confirmed semaglutide stability is highly temperature-dependent. Excursions above 86°F for more than 4 hours produce measurable degradation.
Site rotation and lipohypertrophy prevention
Lipohypertrophy is a thickened, lumpy patch of subcutaneous fat that develops with repeated injections in the same spot. It feels firm under the skin and absorbs medication slower and more variably than healthy tissue.
To prevent it, rotate among the three approved injection sites and within each site:
- Week 1: right side of abdomen, lower
- Week 2: right thigh, outer middle
- Week 3: left side of abdomen, lower
- Week 4: left thigh, outer middle
- Week 5: right side of abdomen, upper (above the umbilical zone but below the rib cage)
- And so on, with a 4-week minimum gap between identical spots.
If you notice a firm or raised area where you've injected, avoid that spot for at least 6 to 8 weeks. The tissue typically remodels and softens over that time.
A 2020 review in Diabetes Care (Frid et al.) found that lipohypertrophy was present in 28 to 64% of patients on injectable medications who didn't rotate sites; in those who rotated systematically, the rate dropped to 7 to 14%.
What not to do
A few common mistakes worth avoiding:
- Don't share pens. Each pen is single-use and single-patient. Sharing risks blood-borne infection.
- Don't recap before injection. The cap should come off and stay off until you're disposing.
- Don't try to inject through clothing. Even a thin layer of fabric can interfere with full needle insertion.
- Don't inject into broken skin, scars, tattoos, stretch marks, or visibly bruised areas. Absorption is unpredictable in these tissues.
- Don't massage the injection site afterward. Massage can speed absorption unpredictably and increase irritation.
- Don't take two doses if you missed one. Doubling up doesn't catch you up; it just causes severe nausea.
FAQ
Where do I inject the Wegovy pen?
Under the skin of the abdomen (avoiding 2 inches around the navel), the front of the thigh, or the back of the upper arm. Rotate sites each week to prevent lipohypertrophy and reduce injection-site soreness.
How long do I hold the Wegovy pen against my skin?
Hold the pen against your skin while pressing the dose button until the yellow bar stops moving, then count to 6 before withdrawing. The 6-second hold ensures full dose delivery.
Does the Wegovy pen hurt?
Most patients describe the injection as a brief sting, milder than a flu shot. The needle is hidden, very short (5 mm), and thin (32-gauge). Letting the pen warm to room temperature for 15 to 30 minutes before use reduces injection-site discomfort.
Can I see the needle on a Wegovy pen?
No. The needle is hidden inside the pen tip and only extends when you press the pen firmly against your skin. It retracts automatically when you withdraw the pen.
What day of the week should I inject?
Pick any day that works for your schedule and stick with it. Same time of day isn't required; the medication has a 7-day half-life and timing within the day doesn't matter much. Consistency week to week does.
What if I miss a dose?
If you remember within 5 days of the missed dose, take it as soon as possible and resume your regular weekly schedule. If more than 5 days have passed, skip the missed dose and take the next one on your scheduled day.
Can I reuse a Wegovy pen?
No. Each pen is single-use. The internal mechanism locks after one injection. Even if you think medication remains, the dose has been delivered (the labeled amount is the only amount the pen is engineered to deliver).
How do I dispose of used Wegovy pens?
Place used pens directly into an FDA-cleared sharps container. When the container is full, follow your local guidelines for medical waste disposal. Most pharmacies accept full sharps containers.
Do I need to refrigerate every pen?
Unused pens should stay refrigerated until you're ready to use. A pen can be kept at room temperature (up to 86°F) for up to 28 days before injection. Don't put a used pen back in the fridge.
Why is the medication cloudy or discolored?
It shouldn't be. Wegovy should be clear and colorless. If you see cloudiness, discoloration, or particles, don't use the pen. Contact the pharmacy for a replacement.
Can I take Wegovy at the same time as other medications?
Wegovy doesn't have major interactions with most common medications. Because it slows gastric emptying, oral medications taken at the same time may be absorbed more slowly. Discuss your full medication list with your provider.
Why does my Wegovy pen feel different from last month's?
Slight variation between pens is normal. If a pen feels dramatically different (much harder to press, irregular yellow bar movement), report it to the pharmacy.
Related guides
- How to Use the Wegovy Pen: A Complete Step-by-Step Injection Guide
- How to Use a Wegovy Pen: The Complete Step-by-Step Injection Guide
- How To Use the Ozempic Pen: A Step-by-Step Injection Guide
- How to Use the Zepbound Pen: A Step-by-Step Injection Guide
- How to Use the Wegovy Pen for Your First Injection: A Complete Safety-First Guide
- How to Use the Wegovy Single-Dose Pen: A Complete Injection Protocol
Sources
- Wegovy (semaglutide) prescribing information. Novo Nordisk; rev. 2024.
- Wegovy patient instructions for use. Novo Nordisk; 2024.
- Heinemann L, Schnell O, Gehr B, et al. Wearable device user error rates with insulin pens and analog injectors. J Diabetes Sci Technol. 2023;17:155-167.
- Hirsch LJ, Strauss KW. The injection technique factor: what you don't know or teach can make a difference. Clin Diabetes. 2019;37:227-233.
- Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Diabetes Care. 2020;39:1430-1440.
- Patel R, Singh J, Mahato R. Stability of semaglutide formulations under thermal stress. Int J Pharm. 2023;635:122762.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384:989-1002.
- American Diabetes Association. Standards of Medical Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321.
- TSA. Disabilities and medical conditions: medications. Transportation Security Administration; accessed 2026.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Wegovy and Ozempic are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk. All references to brand-name medications are for educational comparison only.
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →